Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07600645 · ClinicalTrials.gov registry record · NA
Contact Lens Trial Fitting Experience
A NA study, sponsored by CooperVision International Limited (CVIL).
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07600645: Clinical Trial NA study, sponsored by CooperVision International Limited (CVIL).
NCT07600645 is a NA study that has not yet begun recruiting, run by CooperVision International Limited (CVIL). The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07600645, a NA study, has not yet begun recruiting, sponsored by CooperVision International Limited (CVIL).
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will assess a trial fitting experience with contact lenses.
Primary Outcome
Participant's readiness to finalize a multifocal contact lens prescription after using an at home trial kit based on a scale of 1- 5 (1 - Good and 5 - Bad).
Interventions
- DEVICE Lens A ( stenfilcon A )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-05-31 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What is known before NCT07600645 opens enrollment
NCT07600645 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Lens A ( stenfilcon A ) is the first listed.
NCT07600645 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07600645 about?
NCT07600645 is a clinical study titled "Contact Lens Trial Fitting Experience". This study will assess a trial fitting experience with contact lenses.
What is the current status of trial NCT07600645?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-05-31. Estimated completion is 2026-09-01.
What interventions are being tested in trial NCT07600645?
The interventions under investigation include: Lens A ( stenfilcon A ) (DEVICE).
Who is sponsoring clinical trial NCT07600645?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07600645's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI